Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Adults ages 18 and older may qualify for coverage with a prior authorization by meeting either of the two conditions below: You have already used Wegovy for at least three months at a stable maintenance dose and lost at least 5% of your baseline body weight (or maintained a 5% weight loss)
Researchers still need more information about people already using insulin or sulfonylureas, people with kidney or liver disease, and people with cardiovascular risk factors
Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparatorcontrolled phase 2 trial
Balint B, Jepchumba VK, Guant JL, Guant-Rodriguez RM (2020) Mechanisms of homocysteine-induced damage to the endothelial, medial and adventitial layers of the arterial wall
US$ 28.14
US$ 29.34
US$ 23.69
US$ 21.30
US$ 29.36
US$ 29.22
US$ 23.43
US$ 25.88
US$ 29.26
